Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 1, 2007, Pages 68.e1-68.e6

  Buemi, Michele ^a   Allegra, Alessandro ^a   D'Anna, Rosario ^a   Coppolino, Giuseppe ^a   Crascì, Eleonora ^a   Giordano, Domenico ^a   Loddo, Saverio ^a   Cucinotta, Maria ^a   Musolino, Caterina ^a   Teti, Diana ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

arterial hypertension; circulating endothelial precursors; diabetes mellitus; pregnancy

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GLUCOSE; VASCULOTROPIN RECEPTOR 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; MATERNAL HYPERTENSION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; SYSTOLIC BLOOD PRESSURE;

EID: 33846185094     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.08.032     Document Type: Article

References (36)

1. Rafii S. Circulating endothelial precursor: mystery, reality, and promise. J Clin Invest 105 (2000) 17-19
2. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+) AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
3. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653-660
5. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
6. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 16 suppl 6 (2002) 15-18
7. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) e1-e7
8. Tepper O., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 26 (2002) 2781-2786
9. Imanishi T., Hano T., Sawamura T., and Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31 (2004) 407-413
10. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates re-endothelization. A novel effect involving mobilization and incorporation of bone-marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
11. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
12. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
13. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
14. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
15. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelization after arterial injury. Circulation 108 (2003) 3115-3121
16. Gussin H.A.E., Bischoff F.Z., Hoffman R., and Elias S. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Invest 9 (2002) 357-361
17. Sugawara J., Mitsui-Saito M., Hoshiai T., Habayashi C., Rimura Y., and Kunihiro O. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab 90 (2005) 1845-1848
18. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Gestational diabetes. Obstet Gynecol 98 (2001) 525-538
19. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 77 (2002) 67-75
20. Barnett D., Janossy G., Lubenko A., Matutes A., Newland A., and Reilly J.T. Guidelines for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haematol 21 (1999) 301-308
21. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
22. Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112
23. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34 cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
24. +. Endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98 (2006) 20-25
25. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
26. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
27. Hefler L., Obermair A., Husslein P., Kainz C., and Tempfer C. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acta Obstet Gynecol Scand 79 (2000) 77-78
28. Torry D.S., and Torry R.J. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 37 (1997) 21-29
29. Clark D.E., Smith S.K., Sharkey A.M., and Charnock-Jones D.S. Localization of VEGF and expression of its receptors fit and KDR in human placenta throughout pregnancy. Hum Reprod 11 (1996) 1090-1098
30. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
31. Anthony F.W., Evans P.W., Wheeler T., and Wood P.J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 34 (1997) 276-280
32. Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., et al. Expression of vascular endothelial growth factor and placental growth factor in human placenta. Biol Reprod 56 (1997) 489-494
33. Hirokoshi K., Maeshima Y., Kobayashi K., Matsuura E., Sugiyama H., Yamasaki Y., et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens 18 (2005) 1181-1188
34. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
35. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45 (2005) 1449-1457
36. Baumgartner-Panzer S.M., Wagner L., Pettermann M., Grillari J., Gessl A., and Waldhausl W. High glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44 (1995) 1323-1327